在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Human prokineticin 1(PROK1/EG-VEGF) ELISA kit

  • 中文名稱:
    人前動力蛋白1(PROK1/EG-VEGF)酶聯免疫試劑盒
  • 貨號:
    CSB-E04532h
  • 規格:
    96T/48T
  • 價格:
    ¥3200/¥2500
  • 其他:

產品詳情

  • 產品描述:
    人前動力蛋白1(PROK1/EG-VEGF)酶聯免疫試劑盒(CSB-E04532h)為雙抗夾心法ELISA試劑盒,定量檢測血清樣本中的PROK1含量。試劑盒檢測范圍為0.312 ng/mL-20 ng/mL,適用于探索PROK1在生殖生物學、內分泌調控及血管生成相關疾病中的分子機制;適用于基礎科研中對血清樣本的批量檢測,如生殖系統疾病模型研究、腫瘤微環境分析或激素調控相關實驗,為探索PROK1在生理病理過程中的作用提供可靠工具。本品僅用于科研,不用于臨床診斷,產品具體參數及操作步驟詳見產品說明書。
  • 別名:
    Black mamba toxin related protein ELISA Kit; EG VEGF ELISA Kit; EG-VEGF ELISA Kit; EGVEGF ELISA Kit; Endocrine-gland-derived vascular endothelial growth factor ELISA Kit; Mambakine ELISA Kit; PK1 ELISA Kit; PRK1 ELISA Kit; PROK1 ELISA Kit; PROK1_HUMAN ELISA Kit; Prokineticin 1 ELISA Kit; Prokineticin-1 ELISA Kit
  • 縮寫:
  • Uniprot No.:
  • 種屬:
    Homo sapiens (Human)
  • 樣本類型:
    serum
  • 檢測范圍:
    0.312 ng/mL-20 ng/mL
  • 靈敏度:
    0.078 ng/mL
  • 反應時間:
    1-5h
  • 樣本體積:
    50-100ul
  • 檢測波長:
    450 nm
  • 研究領域:
    Signal Transduction
  • 測定原理:
    quantitative
  • 測定方法:
    Sandwich
  • 精密度:
    Intra-assay Precision (Precision within an assay): CV%<8%
    Three samples of known concentration were tested twenty times on one plate to assess.
    Inter-assay Precision (Precision between assays): CV%<10%
    Three samples of known concentration were tested in twenty assays to assess.
  • 線性度:
    To assess the linearity of the assay, samples were spiked with high concentrations of human EG-VEGF in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
      Sample Serum(n=4)
    1:1 Average % 103
    Range % 100-108
    1:2 Average % 95
    Range % 92-99
    1:4 Average % 88
    Range % 85-92
    1:8 Average % 99
    Range % 96-103
  • 回收率:
    The recovery of human EG-VEGF spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
    Sample Type Average % Recovery Range
    Serum (n=5) 102 100-105
  • 標準曲線:
    These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
    ng/ml OD1 OD2 Average Corrected
    20 2.625 2.741 2.683 2.558
    10 2.268 2.166 2.217 2.092
    5 1.635 1.536 1.586 1.461
    2.5 1.053 1.044 1.049 0.924
    1.25 0.711 0.688 0.700 0.575
    0.625 0.430 0.436 0.433 0.308
    0.312 0.282 0.277 0.280 0.155
    0 0.121 0.129 0.125  
  • 數據處理:
  • 貨期:
    3-5 working days

產品評價

靶點詳情

  • 功能:
    Potently contracts gastrointestinal (GI) smooth muscle. Induces proliferation, migration and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. Has little or no effect on a variety of other endothelial and non-endothelial cell types. Induces proliferation and differentiation, but not migration, of enteric neural crest cells. Directly influences neuroblastoma progression by promoting the proliferation and migration of neuroblastoma cells. Positively regulates PTGS2 expression and prostaglandin synthesis. May play a role in placentation. May play a role in normal and pathological testis angiogenesis.
  • 基因功能參考文獻:
    1. PROK1 or MMP-2 in the amniotic fluid do not have a role in the prediction of adverse pregnancy outcomes. PMID: 29405963
    2. Elevated PROK1 in the first pregnancy trimester is a more effective marker than PAPP-A in the prediction of pre-eclampsia and fetal growth restriction. PMID: 28675948
    3. The VEGF/sVEGF-R1 ratio in follicular fluid on the day of oocyte retrieval in women undergoing IVF procedure, regardless of the type of stimulation protocol, might predict the risk of developing ovarian hyperstimulation syndrome (OHSS). To the best of our knowledge this is the first paper in the literature to show interplay among VEGF, EG-VEGF and sVEGF-R1 and the correlation between their concentration and OHSS risk. PMID: 28820403
    4. These findings demonstrate a novel function of primary cilia in controlling EG-VEGF-regulated trophoblast invasion and reveal the underlying molecular mechanism. PMID: 27736039
    5. miR-346 and miR-582-3p regulate EG-VEGF-induced trophoblast invasion through repressing MMP 2 and MMP 9, and may become novel diagnostic biomarkers or therapeutic targets for EG-VEGF-related obstetric disorders. (c) 2016 BioFactors, 43(2):210-219, 2017. PMID: 27619846
    6. Each follicular fluid (FF) was individually aspirated and FF/serum EG-VEGF, inhibin-a, and FF IGF-1 levels were evaluated. The pregnant group was characterized by increased numbers of WVFs (p = 0.044), a WVE (p = 0.022), and increased levels of FF IGF-1 (p = 0.001) and serum EG-VEGF (p = 0.03). PMID: 27484063
    7. Results show the biological effects of PROK1-V67I on cell functions are similar to those of wild type, and the common variant of V67I may act as a modifier in the PROK1-PROKR system through down-regulation of PROK1 expression. PMID: 26828479
    8. EG-VEGF and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease. PMID: 26475302
    9. The prognosis was poorer in colorectal cancers that expressed both PROK1 and VEGF relative to the cases that expressed only 1 protein, and the expression of both proteins was found to be an independent prognostic factor. PMID: 26318037
    10. PROK1 levels in follicular fluid and fertilization culture media could constitute new predictive noninvasive markers of successful embryo implantation in conventional in vitro fertilization-embryo transfer PMID: 26401590
    11. Simultaneous targeting of both angiogenic growth factors (VEGF/PROK1) may prove more useful in colorectal cancer PMID: 25788276
    12. High Prokineticin 1 protein expression is associated with sporadic colorectal cancer. PMID: 25331005
    13. Expression of PROK1 and PROKR1 was significantly higher in mid-gestation ovaries (17-20 wk) than at earlier gestations (8-11 and 14-16 wk). PMID: 26192875
    14. More importantly this paper argues for EG-VEGF clinical relevance as a potential biomarker of the onset of pregnancy pathologies and discusses its potential usefulness for future therapeutic directions. PMID: 24955357
    15. EG-VEGF and VEGFA systems shared several canonical signaling pathways that may contribute to gene-gene interactions, including the Akt, IL-8, EGFR, MAPK, SRC, VHL, HIF-1A and STAT3. PMID: 24671265
    16. Study corroborates the clinical relevance of the EG-VEGF system in human early pregnancy, and provides evidence for the gene-gene interactions of EG-VEGF and PROKR variants. PMID: 25064403
    17. An increased mRNA expression of PROK1 and LIF could be one of the several abnormalities characterizing the endometrium in women recurrent pregnancy loss. PMID: 25128195
    18. Defective placental maturation is associated with an imbalance of expression of basic fibroblast growth factor (FGF) and PK1. PMID: 23891065
    19. preliminary data suggest a high potential of prokineticin 1 in the success of implantation and pregnancy PMID: 23972922
    20. number of blood vessels in PROK1-positive primary gastrointestinal lesions was higher than that in PROK1-negative primary lesions. CONCLUSION: PROK1 expression might be related to the extent of malignancy in gastrointestinal cancer PMID: 24324064
    21. EG-VEGF as a new placental growth factor acting during the first trimester of pregnancy, established its mechanism of action, and provide evidence for its deregulation in FGR. PMID: 22941044
    22. During the first trimester of pregnancy, hCG and EG-VEGF exhibit the same pattern of expression, suggesting that EG-VEGF is potentially regulated by hCG. PMID: 22138749
    23. Findings, together with the detection of sequence variants in PROKR1, PROK1 and PROKR2 genes associated to HSCR and, in some cases in combination with RET or GDNF mutations, provide evidence to consider them as susceptibility genes for HSCR. PMID: 21858136
    24. Data show that decidualization was associated with increased expression of 428 genes including SCARA5 (181-fold), DKK1 (71-fold) and PROK1 (32-fold), and decreased expression of 230 genes including MMP-7 (35-fold) and SFRP4 (21-fold). PMID: 21858178
    25. identified a novel signalling pathway whereby PROK1 can induce the expression of DKK1 in the human endometrium and first trimester decidua. PMID: 21546446
    26. The data shows that much more PK1 in healthy pregnant women is produced than those suffering from preeclampsia. PMID: 21876489
    27. Prok1 is significantly increased in ppapillary thyroid cancer, and its expression in PTC is related to BRAF mutation. PMID: 21385081
    28. CTGF expression in early pregnancy decidua is regulated by PROK1, via activation of the Gq, PLC, cSrc, EGFR, MAPK/ERK kinase pathway and has a role in cell adhesion. PMID: 21098624
    29. Data show that expression of PK1 and PKR1 was detected in primary MM cells and myeloma cell lines. PMID: 20795791
    30. When endometrial stromal cells from both groups of women were differentiated to decidual phenotype, PROK1 mRNA was up-regulated and PR and HOXA10 mRNA were down-regulated to the same extent. PMID: 20400074
    31. findings identify EG-VEGF as a novel paracrine regulator of trophoblast invasion. We speculate that a failure to correctly down-regulate placental expression of EG-VEGF at the end of the first trimester of pregnancy might lead to PE PMID: 19602057
    32. Altered expression of PROK1 could be one of the several biochemical abnormalities characterizing eutopic endometrium in endometriosis. PMID: 19285664
    33. Treatment of human decidua with a lentiviral miRNA to abolish endogenous PROK1 expression results in a significant reduction in IL-11 expression and secretion PMID: 19801577
    34. EG-VEGF expression was significantly higher in ectopic endometriotic tissue when compared to eutopic samples in infertile women. PMID: 19135668
    35. The role of EG-VEGF in the regulation of angiogenesis in endocrine glands. Review. PMID: 12858543
    36. acting via either PK-R2 or PK-R1, prokineticin 1 may have angiogenic as well as nonangiogenic functions in the ovary PMID: 12915658
    37. Expression of VEGFR-1 mRNA, but not EG-VEGF and the other three VEGF receptors studied, was elevated in preeclamptic vs. normal placentas. PMID: 15126581
    38. Human EG-VEGF may play a role in angiogenesis both during the early endocrine development of testis and in the adult testis as well as in Leydig cell tumor growth. PMID: 15292351
    39. EG-VEGF may only play a role in vascular function of peri-implantation endometrium, but is unlikely to be associated with the etiology of endometrial cancer development. PMID: 16210375
    40. PK1 could be one of the causative factors of age-related macular degeneration (AMD); transgenic mice expressing human PK1 exhibit choroidal neovascularization in a model that may be useful for establishing treatments for the exudative form of AMD. PMID: 16263331
    41. Inverse resgulation of mRNA expression by ovarian cells may suggest that in addition to its angiogenic effects, EG-VEGF/PK-1 may also play other roles in ovary. (review) PMID: 16320832
    42. High EG-VEGF is associated with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma PMID: 17167981
    43. Overexpressed Prk1 conferred Adriamycin resistance in a human embryo kidney cell line. PMID: 17178891
    44. EG-VEGF/Prok-1 signaling has a role in neuroblastoma progression PMID: 17289879
    45. Either EG-VEGF is not exclusive of endocrine organs, or the pancreas should be considered as a functional steroidogenic tissue. PMID: 17683928
    46. PROK1 and PROKR1 expression is elevated in human decidua during early pregnancy PROK1-PROKR1 interaction regulates expression of a host of implantation-related genes. PMID: 18339712
    47. EG-VEGF may enhance cell proliferation through the activation of MAPK pathway, although not through the Akt pathway. PMID: 18571163
    48. High PK1 mRNA levels were observed only in cultured pancreatic stellate cells and microdissected islet cells, but not in cancer cells, and PK1 protein was localized mainly in islets and cancer-associated stromal cells. PMID: 19077468
    49. hCG-mediated LIF expression in the endometrium is dependent on prior induction of PROK1. PMID: 19255255
    50. EG-VEGF protects pancreatic cancer cells from apoptosis through upregulation of myeloid cell leukemia-1, an anti-apoptotic protein of the bcl-2 family. PMID: 19523441

    顯示更多

    收起更多

  • 亞細胞定位:
    Secreted.
  • 蛋白家族:
    AVIT (prokineticin) family
  • 組織特異性:
    Localizes to glandular epithelium, stroma and vascular epithelial cells of first trimester decidua (at protein level). Up-regulated in first trimester decidua when compared with non-pregnant endometrium. Expressed in the steroidogenic glands, ovary, testi
  • 數據庫鏈接:

    HGNC: 18454

    OMIM: 606233

    KEGG: hsa:84432

    STRING: 9606.ENSP00000271331

    UniGene: Hs.514793



主站蜘蛛池模板: √最新版天堂资源网在线| 天天天狠天天碰天天爱| 中文字幕人妻无码一夲道| 国产成人三级一区二区在线观看一| 久久久一本精品99久久精品66| 亚洲日产韩国一二三四区| 国产亚洲精品视觉盛宴| 无套中出丰满人妻无码| 亚洲乱码中文字幕在线| 四虎亚洲精品无码| 人妻系列无码专区免费视频| 色天使久久综合网天天| 国产精品高清网站| 少妇太爽了在线观看免费视频| 久国产精品人妻aⅴ| 奇米777四色成人影视| 精品人妻av区波多野结衣| 国产妇女馒头高清泬20p多毛| 成 人色 网 站 欧美大片在线观看| 亚洲欧美在线观看品| 午夜福利无码不卡在线观看| 人妻无码久久精品| 国产免费看又黄又大又污的胸| 国产美女视频免费观看网址| 日本中文字幕亚洲乱码| 日本妇人成熟免费| 国产亚洲精品久久久久久国| 怡红院成永久免费人视频新的| 国产精品美女久久久网站| 无遮挡国产高潮视频免费观看 | 久久精品国产一区二区免费| 亚洲欧洲无码av一区二区三区| 欧美老熟妇乱xxxxx| 国产农村妇女精品一二区| 久久久久无码精品国产人妻无码| 欧美另类 自拍 亚洲 图区| 黄页网址大全免费观看| 欧美亚洲国产成人一区二区三区 | 久久精品国产网红主播| 人人妻人人爽人人做夜欢视频| aa区一区二区三无码精片|